Food Research: Find way to focus on dietary supplement safety ♦ Living alone can dent healthy diets ♦ Soybean foods may protect menopausal women against osteoporosis

Find way to focus on dietary supplement safety A former principal deputy commissioner of the US Food and Drug Administration is proposing a solution to the current gridlock over the regulation of dietary supplements: focus less on whether these vitamins, minerals and herbal extracts actually do what they claim and instead take important steps to improve their safety.

Soybean foods may protect menopausal women against osteoporosis Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis.

Living alone can dent healthy diets People who live alone are more likely to have unhealthy diets lacking key foods, research has found. The study reported inadequate cooking skills, no partner to go shopping with, the increasing cost of food and a lack of motivation to cook were among the reasons people living alone had different eating practices

Tomatoes get boost in growth, antioxidants from nano-sized nutrients Researchers are using nano-sized nutrients to boost production of food without straining natural resources.

RegeneSlim Appetite Control Dietary Supplement Recalled

August 27, 2014 - Regeneca Worldwide a division of Viva Ceuticals, Inc. Las Vegas, NV is expanding the voluntary nationwide recall of its RegeneSlim appetite control dietary supplement to include lot #823230415, lot #EX0616r 15813, Lot # EX0616R15814 and Lot #11414re5516 because FDA analysis confirmed the presence of DMAA. DMAA is also known as 1,3-dimethylamylamine, methylhexanamine, or geranium extract. DMAA is commonly used as a stimulant, pre-workout, and weight loss ingredient in dietary supplement products. The Food and Drug Administration (FDA) has warned that DMAA is potentially dangerous to health as it can narrow blood vessels and arteries, which can cause a rise in blood pressure or other cardiovascular problems such as shortness of breath, arrhythmias, tightening in the chest, and heart attack. RegeneSlim is purchased by and distributed through a direct sales force within the United States and Puerto Rico, and through online sales, for both personal consumption and retail sales.

RegeneSlim is packaged in approximately 3 1/2” by 3” green and white sachets that contain 2 capsules, with the name RegeneSlim displayed prominently on the front of the sachet.

There have been no illnesses reported to date.

This voluntary recall was the result of FDA analysis confirming the presence of DMAA in RegeneSlim and our company's sampling. The company continues their investigation as to what caused the problem.

Consumers who have purchased RegeneSlim with the above-mentioned lot numbers are advised to immediately stop using the product and are urged to return it to the place of purchase for a full exchange. Consumers with questions may contact the company at 1-949-281-2600 between the hours of 9 a.m. and 6 p.m. PDT. Consumers should contact their physician or healthcare provider if they experience any problems that may be related to taking or using RegeneSlim.

Dietary Supplement, Hydravax Recalled Hydravax Due to Potential Inclusion of a Diuretic

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.

 IQ Formulations, of Sunrise, Florida is initiating a precautionary and proactive recall of all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient. The FDA has advised IQ Formulations that an analysis of a sample from one lot of HYDRAVAX (Lot # 2458, Exp # 07/16) revealed the presence of an undeclared ingredient – a diuretic. Diuretics are prescription drugs and thus, are not listed on the packaging label for HYDRAVAX. Consumers are hereby notified not to use the product.

Possible effects of using a diuretic include an electrolyte imbalance due to water loss. Symptoms include: polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes. Fluid and electrolyte imbalances are the most important concern. Excessive doses of diuretics may elicit hyperkalemia, dehydration, nausea, vomiting and weakness and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy and gastrointestinal irritation. People experiencing these problems should seek immediate medical attention.

No illnesses or consumer complaints have been reported to date in connection with this issue. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

The product comes in a 45 capsule bottle. The recalled HYDRAVAX was distributed nationwide in retail stores and mail order.

Production of the product has been suspended while the company continues their investigation as to the source of the potential unlisted ingredient. IQ Formulations receives this product from the manufacturer in sealed packages and with a certificate of analysis that represents that the product contains only the lawful and legitimate listed ingredients.

All consumers who have purchased HYDRAVAX 45 capsule bottles are urged to return them to the place of purchase for a full refund. Consumers and distributors with questions regarding this recall should contact IQ Formulations Customer Service at Recall@iqformulations.com or by phone at 800-626-1022 from Monday through Friday from 9 am to 5 pm EST. This recall action is being conducted with the knowledge of the FDA.